Search clinical trials for: IO102/IO103
Total 13 results
-
Cliniques universitaires Saint-Luc- Université...RecruitingOropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell CarcinomaBelgium
-
IO BiotechMerck Sharp & Dohme LLC; Syneos HealthActive, not recruitingMetastatic Melanoma | Unresectable MelanomaHungary, Spain, United Kingdom, Australia, France, Italy, United States, Denmark, Germany, Israel, Czechia, Belgium, Netherlands, Turkey, Poland, South Africa
-
Memorial Sloan Kettering Cancer CenterIO BiotechRecruiting
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; Almac; NeoGenomicsRecruitingHead and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Lung Cancer Non Small CellUnited States, Spain, United Kingdom
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; AlmacRecruitingMelanoma | Squamous Cell Carcinoma of Head and NeckUnited States, Australia, Denmark, Spain, France, Germany
-
Inge Marie SvaneRecruitingMetastatic MelanomaDenmark
-
Lene Meldgaard KnudsenIO BiotechTerminatedSmoldering Multiple MyelomaDenmark
-
Herlev and Gentofte HospitalUniversity of CopenhagenCompleted
-
Lars Møller PedersenIO BiotechCompletedChronic Lymphocytic LeukemiaDenmark
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; IO BiotechRecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Immune Response BioPharma, Inc.Unknown